STAT

STAT+: Pharmalittle: Biden wins biotech support despite his policies; WHO sets Covid-19 compensation fund for low-income nations

From a policy perspective, Joe Biden should be biotech’s worst nightmare. But that isn’t stopping major biotech chief executives and investors from personally backing Biden's campaign.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall,, and catch up on our reading. And what about you? This may be your last chance to mail in your ballot. You could boost the economy by shopping for winter wear. Or wish upon a star and make the pandemic go away (wouldn’t that be nice?). Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks